X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Fresenius Kabi Onco. Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Fresenius Kabi Onco. Quarterly Results   (DBPH)

Here are the latest quarterly results of Fresenius Kabi Onco.. For more details, see the Fresenius Kabi Onco. financial fact sheet and Fresenius Kabi Onco. share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Fresenius Kabi Onco. Quarterly Results

No. of Mths
Qtr. Ending
3
Dec-11
3
Mar-12
3
Jun-12
3
Sep-12
3
Dec-12
3
Mar-13
3
Jun-13
3
Sep-13
8-Qtr Chart
Click to enlarge
Net Sales Rs m1,2841,2181,3351,6452,0509321,269961 
Other income Rs m41657729550 
Turnover Rs m1,2881,2191,3411,6502,1279611,324961 
Expenses Rs m1,1471,0781,1121,1651,4378191,1841,250 
Gross profit Rs m13614022448061311385585 
Depreciation Rs m6361626467656975 
Interest Rs m165907300073 
Profit before tax Rs m61211683486237771437 
Tax Rs m17303779140872311 
Profit after tax Rs m44-9131269483-1048426 
Gross profit margin %10.611.516.829.229.912.16.760.9 
Effective tax rate %27.9142.922.022.722.5113.032.42.5 
Net profit margin %3.4-0.79.816.423.6-1.13.844.3 
Diluted EPS Rs 0.3 -0.1 0.8 1.7 3.1 -0.1 0.3 2.7  
Diluted EPS (TTM) Rs 1.6 1.4 1.6 2.7 5.5 5.5 5.0 6.0  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   STRIDES PHARMA SCIENCE  PIRAMAL ENTERPRISES  IPCA LABS  UNICHEM LAB  PFIZER  

Compare FRESENIUS KABI ONCO. With:   STRIDES PHARMA SCIENCE  PIRAMAL ENTERPRISES  IPCA LABS  UNICHEM LAB  PFIZER  

Compare FRESENIUS KABI ONCO. With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

From Urjit Patel to Shaktikanta Das; What Lies Ahead?(Podcast)

The week gone by saw Sensex plunge from 700 points to rise by over 600 points. With a volatile and eventful week, it was a challenge keeping up with the news every day.

Views on news

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

More Views on News

Most Popular

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

It's Almost the Perfect Time to Buy This Safe Stock(The 5 Minute Wrapup)

Dec 6, 2018

My latest StockSelect recommendation ticks all the boxes of a great safe stock.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

Are Foreign Investors Heading Back to the Indian Stock Markets?(Chart Of The Day)

Dec 3, 2018

After months of heavy FII selling, November witnessed a return on foreign money into Indian equities...

DSP Mutual Fund's Sale of DHFL Bonds: Here's What You Need to Know(Outside View)

Dec 5, 2018

PersonalFN explains the probable reason as to why the capital market regulator has initiated DSP Mutual Fund's bond sale that caused DHFL stock to crash.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FRESENIUS KABI ONCO. SHARE PRICE


Jan 2, 2014 (Close)

TRACK FRESENIUS KABI ONCO.

  • Track your investment in FRESENIUS KABI ONCO. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON FRESENIUS KABI ONCO.

FRESENIUS KABI ONCO. - ADCOCK INGRAM COMPARISON

COMPARE FRESENIUS KABI ONCO. WITH

MARKET STATS